Role of chest CT in staging of oropharyngeal cancer: A systematic review

Department of Oral and Maxillofacial Surgery, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY, England, UK.
Head & Neck (Impact Factor: 3.01). 04/2009; 31(4):548-55. DOI: 10.1002/hed.21004
Source: PubMed

ABSTRACT The prevalence of synchronous or metastatic tumors in patients with head and neck squamous cell carcinoma (HNSCC) ranges from 6% to 20% and has implications for prognosis and management of the primary disease. There is no consensus about the role of chest CT prior to definitive treatment patients with HNSCC.
A systematic review of all chest CT studies in relation to HNSCC was performed, together with a review of our local database.
Twenty-four studies were identified in addition to our local data. Prevalence of positive chest CT was 7.93%. Patients were significantly more likely to have a positive chest CT with N2 or N3 neck disease (p = .0062) and stage III or IV disease (p = .0001), and significantly less likely with tumors of the oral cavity (p = .0007).
We advocate chest CT as part of the initial investigations for patients with HNSCC.

Download full-text


Available from: Niall M H Mcleod, Jun 22, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chest computed tomography (CT) is not performed routinely or worldwide as the initial diagnostic procedure for patients with head and neck cancer (HNC). The significance of the chest CT scan for HNC diagnosis has not been thoroughly defined. The present study reports findings in an effort to broaden the acceptance and application of CT for HNC.
    Auris Nasus Larynx 09/2014; 42(1). DOI:10.1016/j.anl.2014.08.013 · 1.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ultrasound (US) is a valuable technique for the assessment of salivary gland disease and regional nodes. When used in combination with fine needle aspiration cytology (FNAC) or core biopsy it has a high sensitivity and specificity in the diagnosis of tumours. The role of additional cross-sectional imaging (computed tomography (CT) or magnetic resonance (MR)) to help with the diagnosis of benign parotid tumours is questionable except when there is deep lobe extension or the suggestion of malignancy. We investigated 37 FNAC-confirmed benign parotid tumours in patients who had undergone both US and CT or MRI investigations, to find out whether cross-sectional imaging had provided any further useful diagnostic information before operation. Three patients had bilateral Warthin tumours. Tumours ranged in size from 11 to 45 mm (mean 22). Of the 37 patients 35 (95%) had a clearly delineated mass in the superficial lobe of the parotid on US and no further information was gained from additional CT or MRI. On US 34 patients (92%) had features suggestive of a benign tumour, and three had features suggestive of malignancy but these were found to be benign on FNAC and after operation. CT or MRI confirmed these suspicious findings. In two different patients the deep margin was not visible on US (suggestive of deep lobe extension) and this was confirmed on MRI. The mean time delay between US and CT or MRI was four weeks (range 1-44). These results suggest that additional imaging is not required in most patients with a sonographically and FNAC confirmed benign lesion confined to the superficial lobe of the parotid and confirmed by FNAC or biopsy examination.
    British Journal of Oral and Maxillofacial Surgery 03/2011; 50(4):333-7. DOI:10.1016/j.bjoms.2011.01.018 · 1.13 Impact Factor
  • Current problems in cancer 09/2012; DOI:10.1016/j.currproblcancer.2012.07.002 · 1.00 Impact Factor